Graft Polymer (UK) PLC - London-based polymer modification and drug delivery systems - Posts widened loss in seven-month period ended December 31 than in its financial year that ended May 31, 2021. Pretax loss widens to £954,000 compared to £451,000. Revenue drops to £219,000 from £520,000. Graft uses a seven-month period as it changes its financial year to match the calendar year, as announced in February.

‘The next 12 to 18 months should also see us entering collaborations for mutual development and production of grafted products. This will help satisfy increasing demand on major international companies for new and enhanced products, with a particular focus on automotive projects where we have already undertaken a number of successful research and development projects,’ says Chair Roby Zomer.

Current stock price: 16.01 pence

12-month change: down 28%

Copyright 2022 Alliance News Limited. All Rights Reserved.